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Recognition of extremophilic 
archaeal viruses by eukaryotic cells: 
a promising nanoplatform from the 
third domain of life
Kristine Buch Uldahl1,*, Linping Wu2,*, Arnaldur Hall2, Pavlos Papathanasiou1, Xu Peng1 & 
Seyed Moein Moghimi2,3
Viruses from the third domain of life, Archaea, exhibit unusual features including extreme stability 
that allow their survival in harsh environments. In addition, these species have never been reported to 
integrate into human or any other eukaryotic genomes, and could thus serve for exploration of novel 
medical nanoplatforms. Here, we selected two archaeal viruses Sulfolobus monocaudavirus 1 (SMV1) 
and Sulfolobus spindle shaped virus 2 (SSV2) owing to their unique spindle shape, hyperthermostable 
and acid-resistant nature and studied their interaction with mammalian cells. Accordingly, we followed 
viral uptake, intracellular trafficking and cell viability in human endothelial cells of brain (hCMEC/
D3 cells) and umbilical vein (HUVEC) origin. Whereas SMV1 is efficiently internalized into both types 
of human cells, SSV2 differentiates between HUVECs and hCMEC/D3 cells, thus opening a path for 
selective cell targeting. On internalization, both viruses localize to the lysosomal compartments. 
Neither SMV1, nor SSV2 induced any detrimental effect on cell morphology, plasma membrane and 
mitochondrial functionality. This is the first study demonstrating recognition of archaeal viruses by 
eukaryotic cells which provides good basis for future exploration of archaeal viruses in bioengineering 
and development of multifunctional vectors.
Viruses are receiving increasing attention as novel nanoplatforms with applications in materials science and 
medicine1. Viruses demonstrate remarkable features including plasticity, coordinated assembly, and site-specific 
delivery of nucleic acids. Viruses are also amenable to genetic engineering, their internal cavity may be filled with 
therapeutic agents, and the functional groups on the virus capsid may be modified with biomolecules, synthetic 
polymers and diagnostic agents2. Accordingly, viruses could provide basis for the development of alternative mul-
tifunctional vectors and theranostic platforms1,3. Within such notions, plant viruses and bacteriophages receive 
special attention, as they are considered non-infectious and non-hazardous in humans4. Another group of viruses 
that fits this criterion is archaeal viruses, a highly diverse and abundant category of viruses from the third domain 
of life, Archaea5, yet their potential remains untapped.
Archaeal viruses offer an ideal search pool for novel nanoplatforms as they have several attractive features. They 
are non-pathogenic, offer unique morphologies, and have specializations to survive in extreme environments6. 
All known archaeal viruses infect extremophilic archaea, and are thus adapted to survive the harsh environments 
of the host, making them extremely stable entities7,8. As a group, archaeal viruses show distinct morphologies 
not found in bacteriophages or plant viruses. These include spindle-, bottle-, and droplet-shape6. Accordingly, 
due to their unique shapes and inherent properties, archaeal viruses may prove as interesting vehicles for differ-
ential targeting of eukaryotic cells. Furthermore, size and shape have been identified as key factors influencing 
circulation half-life, biodistribution and cellular uptake of particulate drug delivery vehicles9,10. Although several 
articles suggest archaeal viruses as promising nanoplatforms7,11,12, to the best of our knowledge no studies have 
1Danish Archaea Centre, Department of Biology, University of Copenhagen, Ole Maaløes vej 5, Copenhagen, 2200, 
Denmark. 2Nanomedicine Research Group, Centre for Pharmaceutical Nanotechnology and Nanotoxicology, 
Department of Pharmacy, University of Copenhagen, Copenhagen, Denmark. 3School of Medicine, Pharmacy and 
Health, Durham University, Wolfson building, Queens campus, Stockton on Tees, TS17 6BS, UK. *These authors 
contributed equally to this work. Correspondence and requests for materials should be addressed to X.P. (email: 
peng@bio.ku.dk) or S.M.M. (email: moein.moghimi@gmail.com)
Received: 23 June 2016
accepted: 19 September 2016
Published: 28 November 2016
OPEN
www.nature.com/scientificreports/
2Scientific RepoRts | 6:37966 | DOI: 10.1038/srep37966
investigated the uptake and intracellular fate of any archaeal virus by human cells; a first step in evaluating their 
potential as a nanoplatform for cellular targeting and manipulation.
Here, we studied two archaeal viruses; Sulfolobus monocaudavirus 1 (SMV1) and Sulfolobus spindle shaped 
virus 2 (SSV2) as candidate nanoplatforms. Both viruses infect hosts from the archaeal genus Sulfolobus which 
are found in volcanic hot springs, and are considered hyperthermophilic acidophiles with optimal growth 
at 80 °C and pH 2–313. The fusellovirus SSV2 is a dsDNA virus with a genome size of 14.8 kb14. The virion is 
spindle-shaped. This shape is only found among archaeal viruses. The virion body has short flexous fibers at one 
pole and is ~60 nm in diameter. SMV1 shares morphological similarity with SSV2, but it is significantly larger 
(120 nm) with a genome size of 48.8 kb15,16. SMV1 and SSV2 were selected owing to their unique spindle-shape, 
hyperthermostable and acid-resistant nature. Furthermore, both species are well-established laboratory strains 
with the potential for up scaling. We have investigated the uptake, intracellular fate, and safety of fluorescently 
labelled SMV1 and SSV2 in two different endothelial cell types of human origin: hCMEC/D3 and HUVEC, pro-
viding the first insights into the interaction between archaeal viruses and eukaryotic cells.
Materials and Methods
Production and purification of virus particles. SSV2 was propagated in S. solfataricus 5E6, a host for 
different viruses as described previously17. SMV1 was propagated in S. islandicus Δ C1C218. Both host cultures 
were grown in Sulfolobus medium supplemented with 0.2% (w/v) tryptone, 0.1% (w/v) yeast extract, 0.2% (w/v) 
sucrose and 0.002% (w/v) uracil (TYS + U medium)13. Cultures were started from − 80 °C stock; cells were trans-
ferred to 50 mL TYS + U medium and incubated at 78 °C. After 24 h of propagation, the cell culture was trans-
ferred to 950 mL of pre-heated (78 °C) TYS + U medium. The culture was grown to an OD600 of 0.2–0.3 (typically 
24 h) at which time-point the host culture was infected with virus isolate (MOI 0.1). The supernatants contain-
ing the virus particles were collected 48–72 h post-infection and concentrated by ultrafiltration using 1,000 kDa 
molecular-weight cut-off (MWCO) centrifugal filter units (Sartorius, Aubagne Cedex, France). Additionally, 
the virus particles were purified by ultracentrifugation through a 10–40% (w/v) continuous Iodixanol gradi-
ent. Continuous gradients were prepared by sequentially layering 10, 20, 30 and 40% (w/v) Iodixanol solu-
tion (OptiPrep™ , Axis-Shield PoC AS, Oslo, Norway) in 10 mM Tris-HCl, pH 6.0 into 14 mL centrifuge tubes 
(Beckman Coulter UK Ltd., High Whickham, Bucks, UK). The gradients were left in the dark at 4 °C overnight 
and then concentrated virus preparations were layered over the gradient (1.0 mL) and centrifuged in a SW-41 
rotor (Beckman Coulter) for 6 h at 95,000 g at 4 °C. An opaque band was visible and recovered and an additional 
concentration step was performed. The virus fraction was washed three times with 10 mL of 10 mM Tris-HCl, pH 
6.0 to remove Iodixanol and to prevent interference with downstream processes. Transmission electron micros-
copy (TEM) was used to confirm the presence of viral particles in the recovered fractions, and the number of 
plaque forming units (PFU)/mL was calculated (see below). The virus preparations were then stored at 4 °C until 
used.
Virus particle labelling. For labelling of viruses, 1.0 μ L of PKH67 (Sigma, St. Louis, MO), a fluorescent 
membrane dye that efficiently labels enveloped viruses non-covalently, was dissolved in 1.0 mL of Diluent C 
(Sigma, St. Louis, MO) immediately before the start of procedures19. Two volumes of diluted PKH67 was added 
to one volume of viral suspension (250.0 μ L), and mixed by pipetting. After 3 min, the reaction was stopped by 
adding three volumes of 1% (w/v) BSA, then incubated for 1 min to allow binding of excess dye. The suspen-
sion was then centrifuged at 20,000 g for 20 min at 4 °C and the supernatant were discarded. Labelled virus were 
re-suspended in 3 mL of 10 mM Tris-HCl, pH 6.0 and centrifuged at 20,000 g for 20 min. The washing step was 
repeated and the final pellet were re-suspended in 250.0 μ L Tris-HCl, pH 6 and stored at 4 °C in the dark.
Determination of virus size and concentration. NanoSight LM20 Nanoparticle Tracking Analysis 
(NTA) (NanoSight, Amesbury, UK), equipped with a sample chamber with a 405 nm blue laser and a Viton fluo-
roelastomer O-ring, was used for determination of the hydrodynamic size distribution and viral concentration 
before and after labelling20. All measurements were performed in triplicate and at room temperature.
Transmission electron microscopy. Viral preparations were placed on a carbon-coated copper grid for 
5 min, and stained with 2.0% (w/v) uranyl acetate for 30 s. Images were recorded using a JEM-1010 transmission 
electron microscope (JEOL, Tokyo, Japan) with a Gatan digital camera 792.
Plaque assays. The approximate virus titer before and after fluorescent labelling was determined by plaque 
assays. Serial dilutions (10.0 μ L) of viral preparations were mixed with a sample (2.0 mL) of the exponentially 
growing host culture (2 × 108 cells); S. islandicus Δ C1C2 for SMV1 infection and S. solfataricus 5E6 for SSV2 
infection, respectively. The mixture was incubated for 30 min at 78 °C to allow the adsorption of the virus to 
the host cells. Immediately following the addition of 2 mL of TYS + U medium containing 0.25% (w/v) Gelrite 
(78 °C), the sample was layered over a premade 0.8% (w/v) Gelrite plate (78 °C). The plates were incubated for 2 
days at 78 °C. SMV1 plaques appeared as small clear halos, whereas SSV2 plaques appeared turbid making them 
difficult to detect and enumerate.
Imaging of infected host cells. From an exponentially growing S. islandicus Δ C1C2 culture (OD600 ~ 0.2), 
5.0 mL were collected and incubated with SMV1 purified stock at an MOI of 10. At 5 and 30 min post infection 
(mpi) 1.0 mL cells were pelleted at 8,000 g for 5 min and then re-suspended in 500 μ L 4% (v/v) formaldehyde. 
After 10 min incubation at room temperature, cells were pelleted at 8,000 g for 3 min then washed with PBS buffer, 
pH 7.4. To permeabilize cells, pellets were suspended in 500 μ L PBS containing 0.1% (v/v) Triton X-100 and 
incubated at room temperature for 15 min. Cells were then washed three times with PBS to thoroughly remove all 
traces of the detergent. Pellets were re-suspended in 100–200 μ L PBS, and 10.0 μ L were spread onto poly-D-lysine 
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coated coverslips. After air-drying, the coverslips were washed with PBS then stained with DAPI (10.0 μ M) for 
15 min at room temperature. After staining cells were washed three times with PBS, a cover glass was placed on 
top and the edges were sealed with clear nail polish. Coverslips were stored in the dark at 4 °C. Differential inter-
ference contrast and fluorescent images were acquired in Volocity (Improvision) with a cooled Orca-ER CCD 
camera (Hamamatsu) mounted on a Zeiss AxioImager Z1 microscope (Carl Zeiss, Germany). All images were 
captured at 100-fold magnification using a Plan-Apochromat 100× , 1.4 NA objective lens.
Cell uptake studies. Human brain capillary endothelial cell line hCMEC/D3, transduced by lentiviral vec-
tors incorporating human telomerase or SV40 T antigen, were grown in EBM-2 medium supplemented with 
5.0% (v/v) FBS, hydrocortisone (1.4 × 10−6 M), basic fibroblast growth factor (1 ng/mL), 1.0% (w/v) penstrep 
and 10 × 10−9 M HEPES16. Human umbilical vein endothelial cells (HUVECs) were grown in DMEM with 20.0% 
(v/v) FBS on gelatin-coated flasks. All cells were maintained at 37 °C in a humidified atmosphere (air supple-
mented with 5% CO2). For the uptake study, hCMEC/D3 cells and HUVEC cells (2 × 104/cm2) were seeded on 
24-well plates (Corning, USA) and grown for 24 h at 37 °C, and 5% CO2 to 60–70% confluence. Afterwards, cells 
were washed three times with pre-warmed PBS and the uptake studies were initiated by adding different con-
centrations of PKH67 labelled viral particles (2.9–23.5 × 1010 particles/mL). After viral challenge for 24 hours, 
the medium was removed and cells were washed three times with pre-warmed PBS and harvested by trypsin-
ization. A total of 10,000 cells, suspended in ice-cold PBS, were analyzed by flow cytometry (FACS Array Cell 
Analysis, BD, USA). For live-cell microscopy and organelle tracking, cells were seeded on eight-well Lab-Tek 
chamber slides (Nunc, Naperville, IL) for 1 day and then labelled with CellLight Reagents BacMam 2.0 Early 
endosomes-GFP, Lysosomes-GFP, Golgi-GFP, Endoplasmic reticulum (ER)-GFP, and Tubulin-GFP in accordance 
with the manufacturer’s protocol. Live cell imaging was performed on a Leica AF6000LX microscope equipped 
with a 63× (numerical aperture 1.47) oil objective using 1.6× magnification and analysed20. The co-localization 
analysis was processed with Image J to calculate Manders’ coefficient as described previously20.
Cell functionality and viability tests. Lactate dehydrogenase (LDH) release, and cell respiration was 
investigated as described in detail elsewhere20,21. LDH release from hCMEC/D3 cells and HUVECs was measured 
at 24 h post incubation with virus using CytoTox96 Non-Radioactive Cytotoxicity Assay kit (Promega). The possi-
ble effects of viruses on cellular respiration were investigated by using XFe96 extracellular flux analyzer and XF96 
V3 cell culture microplates (Seahorse Bioscience)21. Briefly, cells were seeded at 1.0 × 104 cells/well in growth 
medium for 24 h. and thereafter challenged with viruses at 37 °C and 5% CO2 for 24 h. The following day, oxygen 
consumption rate (OCR) was measured at 37 °C in Seahorse assay buffer (containing 10 mM glucose, 10 mM 
pyruvate, at pH 7.4). Different mitochondrial respiratory states were examined through sequential addition of 
different compounds and corrected for non-mitochondrial respiration. To obtain estimations of mitochondrial 
quality following viral challenge, the respiratory ratio (RCR) and the coupling efficiency of OXPHOS were calcu-
lated as described elsewhere21,22. Mitochondrial inhibitors used to obtain mitochondrial respiratory states were 
applied at the following concentrations: oligomycin A (1 μ M), carbonyl cyanide-4-(trifluoromethoxy)phenylhy-
drazone (FCCP; 1.0 μ M), antimycin-A (2.5 μ M) and rotenone (2.5 μ M).
Results and Discussion
Viral morphology and size distribution after PKH67 labelling. Morphological characteristics of 
SMV1 and SSV2 were studied by TEM and representative micrographs are presented in Fig. 1. SMV1 is spin-
dle-shaped with an extending tail at one pole. SMV1 appears both individually and in a rosette-like arrangement, 
where virus-virus interaction appears to be mediated through the tail regions. Although, the general morphol-
ogy of SMV1 remains unaltered after PKH67 labelling, some virions appear more electron dense. SSV2 is also 
spindle-shaped bearing flexous fibres at one pole, but they are smaller than SMV1 (Fig. 1). This species also form 
rosette-like structures of 3–6 virions as seen in TEM (Fig. 1). Again, their morphological characteristics appear to 
be preserved on PKH67 labelling and with some increase in electron density.
NanoSight LM20 Nanoparticle Tracking Analysis (NTA) was used for sizing and counting of viral prepara-
tions. NTA deduces the size on a particle-by-particle basis, relating the changing position of scattering viruses 
under Brownian motion23. NTA, however, assumes sphere equivalent hydrodynamic diameter particle size. 
Accordingly, SMV1 displays a narrow size distribution with a mean sphere equivalent hydrodynamic diameter 
of 114 ± 2 nm (n = 3) and 120 ± 1 nm (n = 3), with corresponding modes of 108 ± 2 nm and 120 ± 3 nm, before 
and after labelling, respectively (Fig. 1). NTA analysis further reveals existence of a small population of ≤ 50 nm 
particles, presumably arising from particulate contaminants and debris that could not be removed during the 
purification steps. This population, however, seems unaffected after labelling. Another interesting feature of the 
NTA analysis is the slight increase in the population of ≥ 150 nm particles after PKH67 labeling, which most likely 
is a reflection of aggregate formation among particles in the 75–100 nm ranges, since their concentration drops 
compared with untreated viruses. These differences are further reflected in scatter plots of relative intensity versus 
particle size, which allow differences in particle composition to be explored. The results reveal broad scattering of 
particles in 50–150 nm size ranges with relative intensities of 1–10 arbitrary units (au), whereas larger particles/
aggregates predominantly scatter with relative intensities < 5 au (Fig. 1). PKH67-labeling causes considerable 
drop in the proportion of high scattering (> 5 au) SMV1 particles, and concomitantly increase the proportion of 
particles that scatter < 5 au, including particles ≥ 150 nm in size.
NTA determination also shows a narrow size distribution for SSV2 with a mean sphere equivalent hydro-
dynamic diameter of 76 ± 1 nm (n = 3), and 75 ± 2 nm (n = 3), with corresponding modes of 63 ± 5 nm, and 
65 ± 4 nm, before and after PKH67 labelling, respectively. Again, a small proportion of small particles (20–30 nm) 
are observable before and after labelling, which may represent the presence of some impurities (Fig. 1). Unlike 
SMV1 preparation, PKH67 did not increase the proportion of larger particles (> 100 nm). Considering the 
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Figure 1. Physical characteristics of viruses before and after labeling with PKH67. (a) SMV1, (b) SMV1-
PKH67, (c) SSV2, (d) SSV2-PKH67. Left panel: Transmission electron micrographs of viruses; Middle: Typical 
size distribution profile and concentration of viral preparations determined by Nanoparticle Tracking Analysis; 
Right panel: 2D plots of relative light scattering intensity of viruses versus the estimate of their size.
www.nature.com/scientificreports/
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hydrodynamic diameter of SSV2, the detection of a minor population of ≥ 150 nm may represent SSV2 rosettes 
that were observed in the electron micrographs. Finally, the scatter-plots show that the bulk of SSV2 particles 
scatter with intensities ≤ 1 au, but after labelling a higher proportion of SSV2 scatter > 1 au (Fig. 1).
Viral infectivity after PKH67 labelling. We infected a culture of the archaeal host, Sulfolobus islandicus 
Δ C1C2, with PKH67 labelled SMV1 to investigate whether PKH67 signal colocalize with the host cells stained 
with DAPI. Co-localization analysis revealed a Pearson’s correlation coefficient (PCC) of ~0.9. Co-localization 
coefficients M1 and M2 demonstrated that ~95% of the green pixels (deriving from PKH67) co-localize with the 
blue DAPI pixels, whereas 65–75% of the blue pixels (host cells) co-localize with the green pixels (Fig. 2a,b). 
These observations suggest that at least the majority of the PKH67 signal is derived from the labelled SMV1, 
which remains infectious. Similarly, PKH67 labelled SSV2 exhibited colocalization with its host S. solfataricus 
5E6 (Supplementary Fig. S1). In addition, we used S. acidocaldarius, a Sulfolobus species which is not a host to 
any known archaeal viruses, to confirm selective infectivity. Indeed, no co-localizing signals were observed with 
DAPI stained S. acidocaldarius cells which were incubated with PKH67-labeled SMV1 under the same condition 
as used for S. islandicus Δ C1C2 (Supplementary Fig. S2).
Potential interference of PKH67 labelling to the viral infectivity was examined by plaque assay with archaeal 
host cells, S. islandicus Δ C1C2 for SMV1 and S. solfataricus 5E6 for SSV2. The results in Fig. 2c confirm that both 
viruses remain infectious after PKH67 labelling, although SSV2 infectivity dropped about 4 folds after PKH67 
labelling. This drop of infectivity after labeling might be due to the smaller size of SSV2 which makes it more 
difficult to pellet SSV2 than SMV1 under the same centrifugation condition. Moreover, the morphology of the 
plaques remained unchanged after PKH67 labelling (Supplementary Fig. S3). However, the plaquing efficiency 
of SSV2 is extremely low and virus titre measured by plaque assays is several orders of magnitude lower than 
actual viral counts, as observed in our laboratory and as reported previously by others14. On the other hand, SSV2 
plaques appear unusually large and each plaque seems to be originated from multiple viral particles. Accordingly, 
the virus titre of SSV2 must be viewed cautiously and we used NTA counts instead for the following experiments.
Collectively, these observations suggest that PKH67 may be used as a specific dye for the labelling and tracing 
of SMV1 and SSV2. As the viral-host infection experiments were carried out at 78 °C, our study demonstrates the 
Figure 2. Infectivity of PKH67 labeled viruses. (a) Host cell imaging of S. islandicus Δ C1C2 infected with 
SMV1. Cells were stained with DAPI and SMV1 particles were labeled with PKH67. The co-localization of 
DAPI stained cells (blue, left panel) with virus particles (green, middle panel) appears as light purple (right 
panel). Bar = 9 μ m. The insets in (a) represent magnified (2x) views of the selected regions. The Pearson’s and 
Mander’s overlap coefficients are represented as the average of 6 individual images of infected cells at initial 
stage of virus infection, 5 min post infection (mpi) and 30 mpi, at an MOI of 10 (Panel b). The infectivity was 
measured by a plaque assay before and after labelling, and presented as PFU/mL (Panel c).
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stability of the PKH67 labelling at high temperatures, thus indicating PKH67 as an option for fluorescent labelling 
used for tracking organisms above physiological temperatures.
Uptake of SMV1 and SSV2 by human endothelial cells and assessment of cellular safety. 
Uptake and intracellular processing of labelled viruses were followed in two phenotypically different human 
endothelial cell types. The results in Fig. 3 show that HUVECs, but not hCMEC/D3, can interact with both 
viruses. SMV1 favourably interacts with hCMEC/D3 cells in a concentration-dependent manner, where the 
proportion of virus-containing cells increases with increasing SMV1 concentration at 24 h post incubation. In 
contrast to SMV1, hCMEC/D3 cells even at high viral concentrations poorly recognize SSV2. Whether viral 
adhesion to and recognition by both cell types is mediated through the viral tail regions remains to be eluci-
dated. Nevertheless, the observed differences in viral recognition may be due to different receptor expression 
and specificity among these cells. Alternatively, these differences may arise from different rates of endocytosis 
and/or cell-dependent non-specificity in uptake (e.g., through macropinocytosis) processes and require detailed 
investigation.
Live-cell microscopy confirmed viral internalization in both cell types (Fig. 4). Free dye molecules were not 
taken up by the cells, when challenged even at higher concentration than the amount of fluorescence in labelled 
viruses (Supplementary Fig. S4). This confirms that cell associated fluorescence is derived from viral uptake. 
Tracking studies further revealed predominant localization of viruses to the peri-nuclear region, and particu-
larly to lysosomal compartments, and therefore consistent with endocytic uptake processes20,24. Due to strong 
fluorescent signal at the peri-nuclear region, we also investigated viral trafficking to endoplasmic reticulum (ER) 
and the Golgi complex. In contrast to the lysosomal compartment, Manders’ fluorescence overlap coefficient 
remains low in both ER and Golgi complex regardless of the virus type. Accordingly, internalization routes such 
as caveolae-independent and lipid raft/caveolae-mediated endocytosis25,26, may operate a minor role in viral 
translocation to these organelles.
Neither SMV1, nor SSV2, induced any deleterious cytotoxic effects. This notion is confirmed from the appar-
ent lack of detrimental effects on cell morphology, LDH release and mitochondrial functionality (Fig. 5) irre-
spective of virus load, type and the endothelial cell type. Viral challenge also showed no significant changes on 
basal respiration, mitochondrial proton leak or maximum respiratory rates (MRR) in either cell lines (Fig. 5). 
This demonstrates that the physiological coupling state of mitochondrial respiration remains unaltered21,22 even 
following cellular exposure to high concentrations of either SMV1 or SSV2. This suggestion is further verified by 
calculations of the coupling efficiency of oxidative phosphorylation (OXPHOS) and the respiratory control ratio 
(RCR) which revealed no significant changes (Table 1).
Figure 3. Cellular uptake of PKH67-labelled viruses by hCMEC/D3 (a,b) and HUVECs (c,d) cells. Left panel: 
Average fluorescence intensity of cells after exposure to increasing concentration of labeled viruses for 24 h 
(a,c); Right panel: Quantification of positive cells bearing PKH67-labelled viruses by FACS (b,d). In all the 
experiments, corresponding cells were incubated with different concentration of either SMV1-PKH67 or SSV2-
PKH67 for 24 h. Viral concentrations were estimated by NTA.
www.nature.com/scientificreports/
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Conclusions and perspective. Our results provide the first insights into the uptake by and behaviour of 
archaeal viruses in two phenotypically different human endothelial cells in vitro. In particular, SSV2 differen-
tiates between HUVECs and hCMEC/D3 cells. The specific recognition and uptake of SMV1 by hCMEC/D3 
cells is also interesting and may provide an alternative approach for possible modulation of brain cerebral capil-
lary endothelial cell functions. However, further studies are needed to determine whether viral interaction with 
Figure 4. Intracellular trafficking of PKH67-labelled viruses in hCMEC/D3 cells and HUVECs. 
Intracellular trafficking (live-cell tracking) of nanoparticles in different organelles after 24 h post-treatment 
with SMV1-PKH67 (a,d) and SSV2-PKH67 (b,e) viruses. Panels (a,b) represent hCMEC/D3 cells and panels 
(d,e) correspond to HUVECs cells. Differential interference contrast (DIC) images were taken simultaneously 
to show morphological changes and fluorescence positioning. Scale bar = 20 μ m. Panels (c) and (f) represent 
Manders’ overlap coefficient after image analysis showing the extent of viral-derived fluorescence overlap with 
the four intracellular compartments in hCMEC/D3 cells and HUVECs, respectively.
www.nature.com/scientificreports/
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mammalian cells is mediated through their tail regions as well as identification of cell surface receptors that par-
ticipate in viral binding and internalization steps.
As a type of prokaryotes different from bacterial cells, anaerobic archaea have been detected in the human oral, 
colonic and vaginal microbial flora demonstrating their ability to colonize the human host11,27,28. However, with 
respect to the safety issue, archaeal viruses have never been reported to integrate into human or any other eukar-
yotic genomes, and archaeal viral sequences have never been detected in the sequences of eukaryotic genomes. 
This can be explained by the fact that all known archaeal viral integration mechanisms need the presence of an 
attachment site and a specific integrase enzyme, which cannot be expressed from the native archaeal viral genome 
in the eukaryotic cellular environment. Thus, as with plant viruses and bacteriophages29, archaeal viruses are less 
likely to trigger negative downstream effects in mammals due to an inability to proliferate.
In terms of engineering viruses for development as nanovectors, two major techniques are implored. These 
include genetic engineering and surface functionalization2. Although no attempts have been made to genetically 
Figure 5. Investigation of cytotoxic effect of viruses in hCMEC/D3 and HUVECs cells. Panel (a) shows the 
extent of lactate dehydrogenase (LDH) release from cells at 24 h post virus treatment. Panels (b–d) shows the 
effect of viral concentration on cellular respiratory states at 24 h post incubation (n = 6). Respiration (indicated 
as the rate of oxygen consumption) was evaluated at basal state (the physiological coupling state controlled 
by cellular energy demand) (panel b), leak state (where respiration is independent of ADP phosphorylation 
and mainly occurs due to proton leak from mitochondrial intermembrane space) (panel c), and maximum 
respiratory rate (MRR; signifying the capacity of the mitochondrial electron transport system) (panel d). 
Blank = untreated cells.
Viruses (×1010/mL)
Coupling efficiency OXPHOS RCR
hCMEC/D3 HUVEC hCMEC/D3 HUVEC
Blank 0.809 ± 0.039 0.874 ± 0.022 10.64 ± 2.06 12.96 ± 2.31
SMV1 (2.94) 0.796 ± 0.015 0.908 ± 0.018 10.79 ± 1.31 12.63 ± 2.47
SMV1 (23.52) 0.791 ± 0.011 0.930 ± 0.047 9.691 ± 0.49 13.10 ± 0.90
SSV2 (2.94) 0.762 ± 0.075 0.893 ± 0.016 10.10 ± 2.05 11.74 ± 1.99
SSV2 (23.52) 0.782 ± 0.014 0.874 ± 0.009 8.99 ± 0.56 12.38 ± 0.75
Table 1.  The coupling efficiency of oxidative phosphorylation (OXPHOS) and mitochondrial respiratory 
control ratio (RCR) in hCMEC/D3 cells and HUVEC cells after 24 h treatment with low and high 
concentration of different archaeal viruses. The coupling efficiency of OXPHOS defines the fraction of 
protons used for mitochondrial ATP production proportional to protons leaking through the mitochondrial 
inner membrane. The RCR denotes the capacity of mitochondria to oxidize respiratory substrates and to 
synthesize ATP. Higher RCR and coupling efficiency of OXPHOS are indicative of mitochondria with high 
efficiency of substrate oxidation and ATP production.
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modify SSV2 or SMV1, a closely related virus to SSV2 has been shown to be amenable to insertion of genetic 
material without loss of function30. Genome comparison between SMV1 and three related genomes, all retrieved 
from hot spring metagenomes, revealed that some genes are not present in all. For example, SMV3 has a much 
larger genome than SMV1, this suggests that large DNA fragments could be inserted into the genome of SMV1 
without loss of function31. Moreover, several archaeal viruses have been made into genetic model systems, prov-
ing the possibility of genetic engineering of archaeal viruses in general32. In addition to genetic engineering or 
by itself, chemoselective chemistry is a powerful tool for incorporating functionalities onto virus scaffolds. Often 
naturally occurring amino acid residues, suitable for functionalization with an appropriate group, are present on 
the viral particle surface. The structures of SMV1 and SSV2 have not been resolved, however, the capsid proteins 
of both viruses contain multiple units of functional groups such as Lys, Asp, and Glu for chemoselective modifi-
cation, thus making it possible for future surface engineering initiatives.
Another important limitation to using viruses as nanovectors is their physical stability. For many of the 
contemplated applications, the improvement of the physical stability of viral nanoparticles may be critical to 
adequately meet the demanding physicochemical conditions they may encounter during production and/or 
storage33. The extremophilic nature of archaeal viruses gives them an inherent stability under a wide range of 
conditions7,8. For example, SMV1 demonstrated high structural stability after treatment under a range of harsh 
conditions including freezing without cryoprotectants16. Even more interesting was that SMV1 retained 100% of 
infectivity after 24 hours storage at − 20 °C16. Taken together with their unique shape, archaeal viruses may show 
great promise as future nanoplatforms in bioengineering and development of multifunctional vectors. However, 
we still need to learn about the interaction between archaeal viruses and the elements of innate immunity to 
determine their safety34.
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